536565 TRIMURTHI

Novelix Pharmaceuticals Share Price

 

 

Start SIP in TRIMURTHI

Start SIP

Performance

  • Low
  • ₹62
  • High
  • ₹63
  • 52 Week Low
  • ₹25
  • 52 Week High
  • ₹70
  • Open Price₹63
  • Previous Close₹61
  • Volume6,363
  • 50 DMA₹58.60
  • 100 DMA₹54.40
  • 200 DMA₹45.79

Investment Returns

  • Over 1 Month + 18.08%
  • Over 3 Month + 3.04%
  • Over 6 Month + 57.27%
  • Over 1 Year + 146.35%

Smart Investing Starts Here Start SIP with Novelix Pharmaceuticals for Steady Growth!

Invest Now

Novelix Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 60.2
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 110
  • P/B Ratio
  • 3.8
  • Average True Range
  • 3.58
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.07
  • RSI
  • 57.59
  • MFI
  • 60.76

Novelix Pharmaceuticals Financials

Novelix Pharmaceuticals Technicals

EMA & SMA

Current Price
₹62.45
+ 1.16 (1.89%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹60.60
  • 50 Day
  • ₹58.60
  • 100 Day
  • ₹54.40
  • 200 Day
  • ₹45.79

Resistance and Support

62.53 Pivot Speed
  • R3 64.97
  • R2 64.18
  • R1 63.32
  • S1 61.67
  • S2 60.88
  • S3 60.02

Novelix Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-13 Quarterly Results
2025-08-14 Quarterly Results & A.G.M.
2025-06-24 Others Inter alia, to consider and approve 1. The conversion of Warrants into Equity Shares of the Company.
2025-05-27 Audited Results

Novelix Pharmaceuticals F&O

Novelix Pharmaceuticals Shareholding Pattern

50.8%
44%
5.2%

Novelix Pharmaceuticals FAQs

Novelix Pharmaceuticals share price is ₹62 As on 16 February, 2026 | 02:19

The Market Cap of Novelix Pharmaceuticals is ₹110 Cr As on 16 February, 2026 | 02:19

The P/E ratio of Novelix Pharmaceuticals is 60.2 As on 16 February, 2026 | 02:19

The PB ratio of Novelix Pharmaceuticals is 3.8 As on 16 February, 2026 | 02:19

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23